G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: Sex-specificity and interactions

American Journal of Hypertension

Volumn 22, Issue 3, 2009, Pages 332-338

  Bhatnagar, Vibha ^a,b   O'Connor, Daniel T ^a   Brophy, Victoria H ^c   Schork, Nicholas J ^d   Richard, Erin ^a,b   Salem, Rany M ^a,b,d   Nievergelt, Caroline M ^e   Bakris, George L ^f   Middleton, John P ^g   Norris, Keith C ^h   Wright, Jackson ^i,j   Hiremath, Leena ^k   Contreras, Gabriel ^l   Appel, Lawrence J ^m   Lipkowitz, Michael S ⁿ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^k THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^l UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^m JOHNS HOPKINS UNIVERSITY   (United States)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE 4; METOPROLOL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRK4 GENE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEPHROSCLEROSIS; PRIORITY JOURNAL; SEX DIFFERENTIATION;

ADRENERGIC BETA-ANTAGONISTS; AFRICAN AMERICANS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DNA; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION, RENAL; MALE; METOPROLOL; MIDDLE AGED; NEPHROSCLEROSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 60549106476     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.341     Document Type: Article

References (19)

1. Neve KA. Novel features of G protein-coupled receptor kinase 4. Mol Pharmacol 2006; 69:673-676.
2. Bengra C, Mifflin TE, Khripin Y, Manunta P, Williams SM, Jose PA, Felder RA. Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem 2002; 48:2131-2140.
3. Gu D, Su S, Ge D, Chen S, Huang J, Li B, Chen R, Qiang B. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006; 47:1147-1154.
4. Wang Y, Li B, Zhao W, Liu P, Zhao Q, Chen S, Li H, Gu D. Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese. Ann Hum Genet 2006; 70:778-783.
5. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004; 22:931-936.
6. Wang Z, Armando I, Asico LD, Escano C, Wang X, Lu Q, Felder RA, Schnackenberg CG, Sibley DR, Eisner GM, Jose PA. The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol 2007; 292:H2083-H2092.
7. Zhu H, Lu Y, Wang X, Snieder H, Treiber FA, Harshfield GA, Dong Y. The G protein-coupled receptor kinase 4 gene modulates stress-induced sodium excretion in black normotensive adolescents. Pediatr Res 2006; 60:440-442.
8. Leineweber K, Rohe P, Beilfuss A, Wolf C, Sporkmann H, Bruck H, Jakob HG, Heusch G, Philipp T, Brodde OE. G-protein-coupled receptor kinase activity in human heart failure: effects of β-adrenoceptor blockade. Cardiovasc Res 2005; 66:512-519.
9. Bhatnagar V, O'Connor DT, Schork NJ, Salem RM, Nievergelt CM, Rana BK, Smith DW, Bakris GL, Middleton JP, Norris KC, Wright JT, Cheek D, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens 2007; 25:2082-2092.
10. Wright JT Jr, Kusek JW, Toto RD, Lee JY, Agodoa LY, Kirk KA, Randall OS, Glassock R. Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials 1996; 17:3S-16S.
11. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288:2421-2431.
12. Wright JT Jr, Agodoa L, Contreras G, Greene T, Douglas JG, Lash J, Randall O, Rogers N, Smith MC, Massry S; African American Study of Kidney Disease and Hypertension Study Group. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med 2002; 162:1636-1643.
13. Wang X, Zhu H, Dong Y, Treiber FA, Snieder H. Effects of angiotensinogen and angiotensin II type I receptor genes on blood pressure and left ventricular mass trajectories in multiethnic youth. Twin Res Hum Genet 2006; 9:393-402.
14. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA, Lusis AJ. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 2006; 16:995-1004.
15. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74:765-769.
16. Suarez-Kurtz G, Pena SD. Pharmacogenomics in the Americas: the impact of genetic admixture. Curr Drug Targets 2006; 7:1649-1658.
17. Nievergelt CM, Libiger O, Schork NJ. Generalized analysis of molecular variance. PLOS Genet 2007; 3:e51.
18. Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int 2002; 62:790-798.
19. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002; 99:3872-3877.